Evaluation of human coronary vasodilator function predicts future coronary atheroma progression

Heart
Samuel L SidhartaMatthew I Worthley

Abstract

Coronary vasodilator function and atherosclerotic plaque progression have both been shown to be associated with adverse cardiovascular events. However, the relationship between these factors and the lipid burden of coronary plaque remains unknown. These experiments focus on investigating the relationship between impaired coronary vasodilator function (endothelium dependent (salbutamol) and endothelium independent (glyceryl trinitrate)) and the natural history of atheroma plaque progression and lipid burden using dual modality intravascular ultrasound (IVUS) and near-infrared spectroscopy (NIRS) imaging. 33 patients with stable chest pain or acute coronary syndrome underwent serial assessment of coronary vasodilator function and intracoronary plaque IVUS and NIRS imaging. Coronary segmental macrovascular response (% change segmental lumen volume (ΔSLV)), plaque burden (per cent atheroma volume (PAV)), lipid core (lipid-rich plaque (LRP) and lipid core burden index (LCBI)) were measured at baseline and after an interval of 12-18 months (n=520 segments). Lipid-negative coronary segments which develop into LRP over the study time period demonstrated impaired endothelial-dependent function (-0.24±2.96 vs 5.60±1.47%, P=0.04) and endo...Continue Reading

References

Jul 1, 1994·Circulation·P BogatyA Maseri
May 16, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·R VirmaniS M Schwartz
Jul 29, 2000·The American Journal of Cardiology·T NeunteuflF Weidinger
Jun 13, 2001·Journal of the American College of Cardiology·Y Y ChirkovJ D Horowitz
Aug 7, 2002·Circulation·Julian P J HalcoxArshed A Quyyumi
May 22, 2010·Journal of the American College of Cardiology·Stephen J NichollsSteven E Nissen
Jan 21, 2011·The New England Journal of Medicine·Gregg W StoneUNKNOWN PROSPECT Investigators
Apr 27, 2011·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Gary S MintzPatrick W Serruys
Jan 19, 2012·Circulation. Cardiovascular Interventions·Ryan D MadderJames A Goldstein
Jan 5, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Dhavalkumar PatelRobert L Wilensky
Sep 23, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Byoung-Joo ChoiAmir Lerman

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.